Back to News
RBC Capital raises Agilent stock price target on pharma strength
Source: Investing.com
No readable financial news content was provided (article text shows only “403”), so key figures, events, and implications cannot be assessed.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- US forces disable ship ‘attempting to run’ Iran blockade in Gulf of Oman
- Middle East war, high debt levels to dominate IMF-World Bank meetings in Bangkok
- Attack on Saudi airport kills 12 people and wounds more than 300—the deadliest strike in any Gulf Arab country since the start of the Iran war
- Musk says Terrafab chip factory could outperform rivals despite challenges
- India’s Rupee Defense Raises Question of How Far RBI Will Go
- CBO chief warns it’s ‘probably not plausible’ that a strong economy alone can steady U.S. debt as 5%-6% growth is needed—more than Bessent’s 3% view
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Can Hedge Funds Use ChatGPT? A Control Framework
- Palantir (PLTR) Q4 2025 Earnings: 70% Revenue Growth, Then an 11% Single-Day Crash